Allianz Life Insurance of North America’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Allianz Life Insurance of North America’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,280	Closed	-$260K	–	34
2017 Q2	$260K	Buy	+2,280	New	+$245K	0.75%	24

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JPCCM

J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return

HFM

Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return

Allianz Life Insurance of North America's FBT Position: Q3 2017 in Review

Allianz Life Insurance of North America sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2017, closing a stake of 2,280 shares — an estimated $260K sold.

Allianz Life Insurance of North America first reported a position in FBT in Q2 2017 and held it in 1 quarter. The position peaked at $260K in Q2 2017. 116 funds tracked by Wall St. Rank hold FBT as of Q3 2017.

Allianz Life Insurance of North America reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2017 after selling out during the quarter.
Allianz Life Insurance of North America sold 2,280 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2017, an estimated $260K.
Allianz Life Insurance of North America first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2017 and held it in 1 quarter.
Allianz Life Insurance of North America's First Trust NYSE Arca Biotechnology Index Fund position peaked at $260K in Q2 2017.
116 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2017.

Based on Allianz Life Insurance of North America's 13F filing for Q3 2017, filed 14 Jun 2018.